–
Denali Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
14.5
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−296
FY22:
−341
FY23:
−197
FY24:
−487
FY25:
−555
(positive)
Change from FY21 to FY25
millions USD
FY21:
−287
FY22:
−330
FY23:
−180
FY24:
–
FY25:
−541
(positive)
Change from FY21 to FY25
millions USD
FY21:
−291
FY22:
−326
FY23:
−145
FY24:
–
FY25:
−512
(positive)
Change from FY21 to FY25
millions USD
FY21:
−291
FY22:
−326
FY23:
−145
FY24:
−423
FY25:
−513
All amounts in millions USD